The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
本发明涉及公式(I)所示的
四氢异喹啉衍
生物,它们是D1的正向变构调节剂,因此在D1受体发挥作用的疾病治疗中作为药物剂有益。